<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03434340</url>
  </required_header>
  <id_info>
    <org_study_id>2017461</org_study_id>
    <nct_id>NCT03434340</nct_id>
  </id_info>
  <brief_title>Aromatherapy for Prevention of Intrathecal Morphine Induced Nausea and Vomiting</brief_title>
  <official_title>Aromatherapy as Prophylaxis for Prevention of Intrathecal Morphine Induced Nausea and Vomiting in Lower Segment Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiti Kebangsaan Malaysia Medical Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universiti Kebangsaan Malaysia Medical Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of combining non pharmacological anti emetic prophylaxis,
      namely peppermint essential oil to granisetron and dexamethasone in patient who receive
      intrathecal morphine for lower segment cesarean section. Half of the patient will receive
      nasal strip containing peppermint essential oil in addition to granisetron and dexamethasone
      while the other half will only receive granisetron and dexamethasone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is not uncommon to use different group of anti emetic in order to achieve high successful
      rate in the prevention of opioid induced nausea and vomiting. This study evaluates the effect
      of combining non pharmacological and pharmacological method to prevent such condition.

      Aromatherapy has been used since many years to treat nausea and vomiting. One of the proposed
      mechanism is by the activation of olfactory receptor when the molecules of essential oil
      absorb in the mucus lining olfactory epithelium. The signal is then carried by olfactory
      sensory neuron to the olfactory bulb which filters and send signal to olfactory cortex as
      well as limbic system to give the feeling of well being.

      Granisetron is a serotonin 3 receptor antagonist prevent or treat nausea and vomiting by
      competitively blocks the action of serotonin at 5-hydroxytryptamine 3 (5HT3) receptors while
      the mechanism of action of dexamethasone; which is a glucocorticoids is not fully understood.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
    <description>Severity of nausea and vomiting is assessed by direct questioning or spontaneous complaint by patient at three time interval; after institution of spinal anesthesia until prior to being discharged from recovery bay, at 6 hour and 24 hour for 1 day. For nausea, severity is assessed using numerical rating scale (NRS). 0 means no nausea while 10 means worst imaginable nausea. As for vomiting, number of occurrence indicates severity. 1-2 times is considered mild, 3-5 times is moderate and more than 5 times is severe.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">156</enrollment>
  <condition>Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Granisetron &amp; Dexamethasone &amp; Peppermint essential oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Granisetron 1mg and Dexamethasone 4mg administer as intravenous injection once right after delivery of newborn followed by Peppermint essential oil 2 drops on nasal strip applied for 6 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Granisetron &amp; Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Granisetron 1mg and Dexamethasone 4mg administer as intravenous injection once right after delivery of newborn</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Peppermint essential oil</intervention_name>
    <description>2 drops applied on a nasal strip</description>
    <arm_group_label>Granisetron &amp; Dexamethasone &amp; Peppermint essential oil</arm_group_label>
    <other_name>YoungLiving®, 100% pure Peppermint essential oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Granisetron</intervention_name>
    <description>1mg intravenous injection</description>
    <arm_group_label>Granisetron &amp; Dexamethasone &amp; Peppermint essential oil</arm_group_label>
    <arm_group_label>Granisetron &amp; Dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>4mg intravenous injection</description>
    <arm_group_label>Granisetron &amp; Dexamethasone &amp; Peppermint essential oil</arm_group_label>
    <arm_group_label>Granisetron &amp; Dexamethasone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) I and II.

          -  Non-smoker.

          -  BMI &lt; 40

          -  Singleton pregnancy

        Exclusion Criteria:

          -  Patient with known allergy to granisetron, dexamethasone, bupivacaine, fentanyl,
             morphine, paracetamol, celecoxib, ginger oil.

          -  Patient who has inability to breathe through nose.

          -  Patient with history of post-operative nausea and vomiting (PONV) or motion sickness
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Assoc Prof Dr Raha Abdul Rahman</last_name>
    <phone>0193373792</phone>
    <email>raha@ppukm.ukm.edu.my</email>
  </overall_contact>
  <reference>
    <citation>Ravindran J. Rising caesarean section rates in public hospitals in Malaysia 2006. Med J Malaysia. 2008 Dec;63(5):434-5.</citation>
    <PMID>19803313</PMID>
  </reference>
  <reference>
    <citation>Hines S, Steels E, Chang A, Gibbons K. Aromatherapy for treatment of postoperative nausea and vomiting. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD007598. doi: 10.1002/14651858.CD007598.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Mar 10;3:CD007598.</citation>
    <PMID>22513952</PMID>
  </reference>
  <reference>
    <citation>Stoicea N, Gan TJ, Joseph N, Uribe A, Pandya J, Dalal R, Bergese SD. Alternative Therapies for the Prevention of Postoperative Nausea and Vomiting. Front Med (Lausanne). 2015 Dec 16;2:87. doi: 10.3389/fmed.2015.00087. eCollection 2015. Review.</citation>
    <PMID>26734609</PMID>
  </reference>
  <reference>
    <citation>Carvalho FA, Tenório SB. Comparative study between doses of intrathecal morphine for analgesia after caesarean. Braz J Anesthesiol. 2013 Nov-Dec;63(6):492-9. doi: 10.1016/j.bjane.2013.01.001. Epub 2013 Dec 5.</citation>
    <PMID>24565347</PMID>
  </reference>
  <reference>
    <citation>Allen TK, Jones CA, Habib AS. Dexamethasone for the prophylaxis of postoperative nausea and vomiting associated with neuraxial morphine administration: a systematic review and meta-analysis. Anesth Analg. 2012 Apr;114(4):813-22. doi: 10.1213/ANE.0b013e318247f628. Epub 2012 Feb 17. Review.</citation>
    <PMID>22344239</PMID>
  </reference>
  <reference>
    <citation>Gehling M, Tryba M. Risks and side-effects of intrathecal morphine combined with spinal anaesthesia: a meta-analysis. Anaesthesia. 2009 Jun;64(6):643-51. Review.</citation>
    <PMID>19462494</PMID>
  </reference>
  <reference>
    <citation>Gan TJ, Diemunsch P, Habib AS, Kovac A, Kranke P, Meyer TA, Watcha M, Chung F, Angus S, Apfel CC, Bergese SD, Candiotti KA, Chan MT, Davis PJ, Hooper VD, Lagoo-Deenadayalan S, Myles P, Nezat G, Philip BK, Tramèr MR; Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014 Jan;118(1):85-113. doi: 10.1213/ANE.0000000000000002. Erratum in: Anesth Analg. 2015 Feb;120(2):494. Anesth Analg. 2014 Mar;118(3):689.</citation>
    <PMID>24356162</PMID>
  </reference>
  <reference>
    <citation>Shanazi M, Farshbaf Khalili A, Kamalifard M, Asghari Jafarabadi M, Masoudin K, Esmaeli F. Comparison of the Effects of Lanolin, Peppermint, and Dexpanthenol Creams on Treatment of Traumatic Nipples in Breastfeeding Mothers. J Caring Sci. 2015 Dec 1;4(4):297-307. doi: 10.15171/jcs.2015.030. eCollection 2015 Dec.</citation>
    <PMID>26744729</PMID>
  </reference>
  <reference>
    <citation>Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000 Jun;50(455):493-6. Review.</citation>
    <PMID>10962794</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peppermint oil</keyword>
  <keyword>morphine</keyword>
  <keyword>nausea and vomiting</keyword>
  <keyword>lower segment cesarean section</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Granisetron</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

